ASCLETIS-B (01672) spent 2.4937 million Hong Kong dollars to repurchase 200,000 shares on December 22nd.
Ka Li Pharmaceutical-B (01672) announced that on December 22, 2025, the company spent HK$2.4937 million to repurchase 200,000 shares.
ASCLETIS-B (01672) announced on December 22, 2025 that the company will spend 2.4937 million Hong Kong dollars to repurchase 200,000 shares.
Related Articles
ENM HOLDINGS(00128): The company has not made any decisions yet, while the land exchange application for Xian Da Land is still in progress.
KIN PANG HLDGS(01722) Subsidiary receives letter of intent for construction contract in Macau.
BOYAA (00434) spent 723,100 Hong Kong dollars repurchasing 200,000 shares on December 22nd.
ENM HOLDINGS(00128): The company has not made any decisions yet, while the land exchange application for Xian Da Land is still in progress.
KIN PANG HLDGS(01722) Subsidiary receives letter of intent for construction contract in Macau.
BOYAA (00434) spent 723,100 Hong Kong dollars repurchasing 200,000 shares on December 22nd.
